These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15855705)

  • 21. Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.
    Katare YK; Daya RP; Sookram Gray C; Luckham RE; Bhandari J; Chauhan AS; Mishra RK
    Mol Pharm; 2015 Sep; 12(9):3380-8. PubMed ID: 26226403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol.
    Schiller D; Zuckerman L; Weiner I
    J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters.
    Vriend J; Dreger L
    Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
    Gruber SH; Nomikos GG; Mathé AA
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
    Ma J; Ye N; Cohen BM
    Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics.
    Hyttel J
    Psychopharmacology (Berl); 1977 Jan; 51(2):205-7. PubMed ID: 14353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in guinea-pig brain.
    Tooney PA; Anderson WB; Lynch-Frame A; Chahl LA
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):155-9. PubMed ID: 15936530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment.
    Zhang Y; Xu H; He J; Yan B; Jiang W; Li X; Li XM
    Neurosci Lett; 2007 Jun; 420(1):66-71. PubMed ID: 17466452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of co administration of haloperidol and large neutral amino acids (tryptophan and valine) on rats striatal dopamine, serotonin and their metabolism.
    Ali O; Haleem DJ; Obaid R; Kamil N; Haleem MA; Ahmed SW
    Pak J Pharm Sci; 2003 Jan; 16(1):13-25. PubMed ID: 16414563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haloperidol decanoate: injection site reactions.
    Maharaj K; Guttmacher LB; Moeller R
    J Clin Psychiatry; 1995 Apr; 56(4):172-3. PubMed ID: 7713859
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of chronic treatment with haloperidol on [3H]PK 11195 binding in the rat brain and peripheral tissues.
    Kurumaji A; Kaneko K; Toru M
    Neuropharmacology; 1996; 35(8):1075-9. PubMed ID: 9121610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain dopamine receptors.
    Seeman P
    Pharmacol Rev; 1980 Sep; 32(3):229-313. PubMed ID: 6117090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.